In the wake of Friday night’s New York Times story on the Avandia controversy (see our summary here), the Senate Finance Committee has posted its 334 page report, as well as a press release and the contents of its letter to FDA Commissioner Margaret Hamburg. GlaxoSmithKline has released its own press release in which the company rejects the conclusions reported in the story.

Here are links to the documents:

• Press Release from US Senate Committee on Finance
• Staff Report from US Senate Committee on Finance
• Letter from Senators Baucus and Grassley to FDA Commissioner
• Press Release: GSK rejects conclusions reported in The New York Times story on Avandia